ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Centrosomal JAK2 Tyrosine Kinase Regulates Primary Cilia Length, Cell Proliferation, and Cilia Orientation During Cell Migration.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Centrosomal JAK2 Tyrosine Kinase Regulates Primary Cilia Length, Cell Proliferation, and Cilia Orientation During Cell Migration.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Janus kinase 2 (JAK2) is best known for its role in cytokine signaling at the plasma membrane, but whether it contributes to primary cilium function is unknown. Here we show that JAK2 localizes predominantly to the daughter centriole of the primary cilium in 3T3-F442A fibroblasts and regulates cilia length and orientation as well as directional cell migration. Growth hormone (GH) stimulates relocation of growth hormone receptor to the cilium and shortens cilia, whereas pharmacological JAK2 inhibition or CRISPR-mediated JAK2 knockout (KO) results in cilia elongation. Using a nocodazole washout assay, we find that JAK2 activity is required for proper control of cilia length during cilia re-assembly. Centrosomal localization of JAK2 depends on both its SH2 domain and kinase activity, and JAK2 clones deficient in centrosomal targeting or kinase function demonstrate impaired control of cilia length and reduced cell proliferation compared with parental and JAK2 WT cells. Depletion of centrosomes by centrinone B or loss of centrosomal JAK2 impairs wound-healing migration and disrupts alignment of primary cilia toward the direction of movement. JAK2 copurifies with the actin-regulating proteins PAK1 and Filamin A in centrosomal fractions, and JAK2 activity is required for Filamin A centrosomal association. Together, our data identify centrosomal JAK2 as a critical regulator of primary cilia architecture and orientation during cell migration, supporting a model in which a JAK2-PAK1-Filamin A signaling complex contributes to cilia-dependent control of cell motility and cell proliferation and suggests new mechanisms by which cytokine signaling interfaces with cilia-dependent cell behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.